Absolute Antibody's murine bispecific reagents enable researchers and drug developers to more easily evaluate potential bispecific combinations in mouse models.
The GIBCO CTS LV-MAX Lentiviral Production System, from Thermo Fisher Scientific, is a complete lentivirus production solution designed to produce high-titre lentiviral vectors.
The Anti-Alpaca secondary antibody product line targets the IgG repertoire of camelid immunoglobulins, including whole molecule, subclass and VHH domain specificities. They are raised against alpaca and cross-react with llama.
Scientists have developed a new antibody technology that combines the advantages of antibody-based therapies with the convenience of oral drug administration.
An antimicrobial coating made of precious metals has reduced growth of bacteria on contamination-prone surfaces inside the International Space Station.
Cayman's line of MaxSpec standards and kits are designed to enable quantitative accuracy and interlaboratory reproducibility in mass spectrometry analysis.
Researchers have found a new way to completely peel off slimy bacterial biofilms.
Biotechnology company IONTAS has announced a panel of human antibodies that neutralise elements of black mamba snake toxin in an in vivo model.
Bio-Rad Laboratories has launched a range of recombinant monoclonal anti-ranibizumab antibodies that are highly specific for the monoclonal antibody drug ranibizumab (Lucentis) or the complex of ranibizumab with its target, vascular endothelial growth factor A (VEGF-A).